BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pillon M, Carucci NS, Mainardi C, Carraro E, Zuliani M, Chemello L, Calore E, Tumino M, Varotto S, Toffolutti T, Destro R, Gazzola MV, Alaggio R, Basso G, Messina C. Focal nodular hyperplasia of the liver: an emerging complication of hematopoietic SCT in children. Bone Marrow Transplant 2015;50:414-9. [PMID: 25581411 DOI: 10.1038/bmt.2014.276] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Vassallo L, Fasciano M, Fortunato M, Orcioni GF, Vavala' T, Regge D. Focal nodular hyperplasia after oxaliplatin-based chemotherapy: A diagnostic challenge. Radiology Case Reports 2022;17:1858-65. [DOI: 10.1016/j.radcr.2022.03.020] [Reference Citation Analysis]
2 Shelmerdine SC, Chavhan GB, Babyn PS, Nathan PC, Kaste SC. Imaging of late complications of cancer therapy in children. Pediatr Radiol 2017;47:254-66. [DOI: 10.1007/s00247-016-3708-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
3 Earl B, Yang ZF, Rao H, Cheng G, Wall D, Ngan BY. A Novel Secondary Neoplasm Following Allogeneic Hematopoietic Stem Cell Transplant: Mixed Donor-Recipient Primitive Mesenchymal Proliferation of the Liver. Pediatr Dev Pathol 2021;24:366-70. [PMID: 33729851 DOI: 10.1177/10935266211001656] [Reference Citation Analysis]
4 Myers L, Ahn J. Focal Nodular Hyperplasia and Hepatic Adenoma: Evaluation and Management. Clin Liver Dis 2020;24:389-403. [PMID: 32620279 DOI: 10.1016/j.cld.2020.04.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
5 Bardi E, Mulder RL, van Dalen EC, Bhatt NS, Ruble KA, Burgis J, Castellino SM, Constine LS, den Hoed CM, Green DM, Koot BGP, Levitt G, Szonyi L, Wallace WH, Skinner R, Hudson MM, Kremer LCM, Effinger KE, Bresters D. Late hepatic toxicity surveillance for survivors of childhood, adolescent and young adult cancer: Recommendations from the international late effects of childhood cancer guideline harmonization group. Cancer Treat Rev 2021;100:102296. [PMID: 34571378 DOI: 10.1016/j.ctrv.2021.102296] [Reference Citation Analysis]
6 Ji Y, Chen S, Xiang B, Wen T, Yang J, Zhong L, Li F, Li L. Clinical Features of Focal Nodular Hyperplasia of the Liver in Children. J Pediatr Gastroenterol Nutr 2016;62:813-8. [PMID: 26704863 DOI: 10.1097/MPG.0000000000001094] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
7 Torbenson MS. Hamartomas and malformations of the liver. Seminars in Diagnostic Pathology 2019;36:39-47. [DOI: 10.1053/j.semdp.2018.11.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
8 Hobbie WL, Li Y, Carlson C, Goldfarb S, Laskin B, Denburg M, Goldmuntz E, Mostoufi-Moab S, Wilkes J, Smith K, Sacks N, Szalda D, Ginsberg JP. Late effects in survivors of high-risk neuroblastoma following stem cell transplant with and without total body irradiation. Pediatr Blood Cancer 2021;:e29537. [PMID: 34971017 DOI: 10.1002/pbc.29537] [Reference Citation Analysis]
9 Verhagen MV, Ciocarlie O, Humphries P, Watson T. Contrast-enhanced ultrasound for multiple liver lesions after bone marrow transplant in a child with leukaemia: Multifocal focal nodular hyperplasia. Ultrasound. 2019;27:122-126. [PMID: 31037096 DOI: 10.1177/1742271x18795328] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Cattoni A, Rovelli A, Prunotto G, Bonanomi S, Invernizzi P, Perego R, Mariani AM, Balduzzi A. Hepatic focal nodular hyperplasia after pediatric hematopoietic stem cell transplantation: The impact of hormonal replacement therapy and iron overload. Pediatr Blood Cancer 2020;67:e28137. [PMID: 31889398 DOI: 10.1002/pbc.28137] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
11 Furlan A, Brancatelli G, Burgio MD, Grazioli L, Lee JM, Murmura E, Lucidarme O, Strauss C, Rode A, Ronot M, Vilgrain V. Focal Nodular Hyperplasia After Treatment With Oxaliplatin: A Multiinstitutional Series of Cases Diagnosed at MRI. American Journal of Roentgenology 2018;210:775-9. [DOI: 10.2214/ajr.17.18867] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
12 Zarfati A, Chambers G, Pio L, Guerin F, Fouquet V, Franchi-Abella S, Branchereau S. Management of focal nodular hyperplasia of the liver: Experience of 50 pediatric patients in a tertiary center. J Pediatr Surg 2020;55:1885-91. [PMID: 32057440 DOI: 10.1016/j.jpedsurg.2020.01.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Vernuccio F, Ronot M, Dioguardi Burgio M, Lebigot J, Allaham W, Aubé C, Brancatelli G, Vilgrain V. Uncommon evolutions and complications of common benign liver lesions. Abdom Radiol (NY) 2018;43:2075-96. [PMID: 29260281 DOI: 10.1007/s00261-017-1427-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]